XML 20 R2.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Assets    
Cash and cash equivalents $ 96,816 $ 59,968
Restricted cash 131,406 154,657
Loans receivable at fair value 2,755,470 2,778,523
Capitalized software and other intangibles, net 78,279 86,588
Right of use assets - operating 9,718 9,775
Other assets 129,397 137,592
Total assets 3,201,086 3,227,103
Liabilities    
Secured financing 331,081 535,469
Asset-backed notes at fair value 617,904 1,080,690
Asset-backed borrowings at amortized cost 1,605,597 984,333
Corporate financing 193,944 203,751
Lease liabilities 14,969 18,200
Other liabilities 61,602 50,851
Total liabilities 2,825,097 2,873,294
Stockholders' equity    
Common stock, $0.0001 par value - 1,000,000,000 shares authorized at June 30, 2025 and December 31, 2024; 44,281,422 shares issued and 44,009,399 shares outstanding at June 30, 2025; 36,383,879 shares issued and 36,111,856 shares outstanding at December 31, 2024 8 7
Common stock, additional paid-in capital 618,177 612,642
Accumulated deficit (235,887) (252,531)
Treasury stock at cost, 272,023 shares at June 30, 2025 and December 31, 2024 (6,309) (6,309)
Total stockholders’ equity 375,989 353,809
Total liabilities and stockholders' equity $ 3,201,086 $ 3,227,103